Company / Operating Income per Share
Tempest Therapeutics, Inc. Operating Income per Share History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.02
FY2017
5-year range
-$2.02 / -$1.21
FY2015-FY2017
Trend
-15.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-1.21 to $-2.02 over the past 2 years.
Based on SEC 10-K filings.
-2.02 in FY2017.
Declined from $-1.21 to $-2.02 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating income per share decreased 15.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$2.02 | -15.0% |
| FY2016 | -$1.76 | -45.2% |
| FY2015 | -$1.21 | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026